Phase I/II Study to Evaluate the Efficacy and Safety of a Combination Chemotherapy
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00424840|
Recruitment Status : Completed
First Posted : January 22, 2007
Last Update Posted : November 19, 2014
University of Massachusetts, Worcester
Millennium Pharmaceuticals, Inc.
Information provided by (Responsible Party):
William Walsh, University of Massachusetts, Worcester
Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
|Recruitment Status :||Completed|
|Actual Primary Completion Date :||March 2014|
|Actual Study Completion Date :||March 2014|
|Submission Cycle||Results Submitted to ClinicalTrials.gov||Results Returned after Quality Control Review|
|1||June 17, 2016||July 29, 2016|
|2||October 7, 2016||November 30, 2016|
|3||February 22, 2017||April 7, 2017|
Simon R. Optimal two-stage designs for phase II clinical trials. Control Clin Trials. 1989 Mar;10(1):1-10.